When I first saw the biospectrum story in Dec
http://www.biospectrumasia.com/biospectrum/news/122648/phosphagenics-start-opioid-pain-patch-study#.UPXpzYlhjTo
I didn't really take any notice of the picture attached showing a small thumb sized patch as I presumed it was a stock biospectrum photo. I am however reliably informed that this is a very good indication of the actual oxymorphone patch - an opiod that is 3 times as powerful as oxycodone has allowed the company to reduce the size of the patch by similar proportions.
oxymorphone trials begin, page-10
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |